Hand and foot syndrome secondary to capecitabine

Hand and foot syndrome are an adverse effect often seen with chemotherapy or with the use of biologics. It is characterised by painful erythema and edema, dry or moist desquamation of palms and soles in mild to moderate case. Severe cases usually present with cracking, peeling, blister, ulcer and severe pain. Here we report a 65-year-old woman with breast carcinoma who was on treatment with capecitabine and presented with fissuring and bleeding over palms and soles, with progressive burning sensation. On examination, hyperpigmentation and scaling were also noted over both palms and soles. She was diagnosed with hand and foot syndrome and was treated with emollients, antibiotics and topical steroids.

[1]  H. Komatsu,et al.  Unmet needs of cancer patients with chemotherapy-related hand-foot syndrome and targeted therapy-related hand-foot skin reaction: A qualitative study. , 2019, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[2]  Hina Lal Hand and foot syndrome secondary to capecitabine. , 2014, Indian Journal of Dermatology, Venereology and Leprology.

[3]  Sudhir Kumar,et al.  Capecitabine-induced hand-foot syndrome , 2014 .

[4]  J. Zekri,et al.  Hyperpigmentation of the tongue, palms and soles: Rare side effect of capecitabine , 2013 .

[5]  Gabriella Fabbrocini,et al.  Chemotherapy and skin reactions , 2012, Journal of experimental & clinical cancer research : CR.

[6]  G. Casas,et al.  Cutaneous manifestations of new oncologic drugs: epidermal growth factor receptor inhibitors and 5-fl uorouracil prodrugs , 2010 .

[7]  R. Elledge,et al.  A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  M. Summerhayes,et al.  The “Handfoot Syndrome” occurring with chronic administration of Etoposide , 1992, European journal of haematology.

[9]  H. Gadner,et al.  Toxic skin reaction restricted to palms and soles after high-dose methotrexate. , 1991, Pediatric hematology and oncology.

[10]  J. Lokich,et al.  Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. , 1984, Annals of internal medicine.